RecruitingNCT05540561

Biological Diagnosis and Monitoring of Chronic Nitrous Oxide Abuse

Biological Alterations of Laughing Gas Outcomes in Neurology


Sponsor

University Hospital, Lille

Enrollment

356 participants

Start Date

Jan 30, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

There is a toxicity linked to the chronic use of nitrous oxide, leading to neurological disorders such as combined sclerosis of the spinal cord. One thus frequently observes patients presenting disorders of walking or paresthesias, of more or less resolving evolution being able to go until the need for using a wheelchair and more recently cases of thrombosis were reported Serum or urine N2O assays are rarely performed routinely, because they do not allow to ensure a real exposure due to the very short half-life of this gas in the body. Thus, other biological monitoring markers are mentioned in the literature, such as vitamin B12 or homocysteine. Unfortunately, there are still no recommendations for biological monitoring of nitrous oxide consumption. Moreover, underlying mechanisms leading to clinical outcomes remains misunderstood.


Eligibility

Min Age: 14 YearsMax Age: 65 Years

Inclusion Criteria6

  • A current or former recreational nitrous oxide user defined
  • With associated clinical signs (group 1)
  • Without associated clinical signs (group 2)
  • With or without clinico-biological sequelae associated with use
  • Consenting to the conduct of the study
  • Socially insured

Exclusion Criteria4

  • Pregnant or breastfeeding women
  • Never used nitrous oxide or stopped using it more than 6 months ago
  • Lack of social security coverage
  • Not willing to participate in the entire study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERblood collection

Biological analyses in the framework of care with conservation of blood samples


Locations(8)

BETHUNE

Béthune, France

Boulogne Sur Mer

Boulogne-sur-Mer, France

CALAIS

Calais, France

Lens

Lens, France

Chu Lille

Lille, France

Nantes

Nantes, France

Roubaix

Roubaix, France

Rouen

Rouen, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05540561


Related Trials